Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma

Ahmed I.I.K., Sadruddin O., Panarelli J.F.

2023
Eye and Vision

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

John Moran Eye Center, University of Utah, Salt Lake City, UT, United States; University of Toronto, Toronto, ON, Canada; Prism Eye Institute, Mississauga, ON, Canada; Santen Inc, Emeryville, CA, United States; New York University, New York, NY, United States

Related Publications

Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive rats

Taniguchi T, Akaishi T, Hata T, Yamashita R, Esaki Y, Morofuji R, Okabe K, Fuwa M, Yamamoto Y, Guo L, Choi S, Luong V, Ota T, Sharif NA, Cordeiro MF, Kageyama M.

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.

Valproic Acid Application to Modify Post Surgical Fibrosis in a Model of Minimally Invasive Bleb Surgery

Lo P.F.; Gunawan M.; Yap Z.L.; Leong C.; Kwek F.; Varadarajan J.; Wang X.; Kageyama M.; Wong T.T.

View all Glaucoma publications